ioCells, developed by bit.bio, is a groundbreaking initiative in the field of biomedical research. This project offers precisely programmed human cells derived from iPSCs (induced pluripotent stem cells), utilizing the cutting-edge opti-ox™ technology. The goal is to provide standardized, easily accessible human cells for fundamental disease research and drug discovery. ioCells are designed to overcome challenges like data reproducibility, unreliable and physiologically irrelevant cell models, and lengthy experimental timelines, thus accelerating advancements in human health. For more detailed information, visit bit.bio's ioCells page.

Basic information

Country

UK

Group Name

bit.bio

Source

Source